These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23547239)

  • 1. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia.
    Myers JE; Tuytten R; Thomas G; Laroy W; Kas K; Vanpoucke G; Roberts CT; Kenny LC; Simpson NA; Baker PN; North RA
    Hypertension; 2013 Jun; 61(6):1281-8. PubMed ID: 23547239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study.
    Kenny LC; Black MA; Poston L; Taylor R; Myers JE; Baker PN; McCowan LM; Simpson NA; Dekker GA; Roberts CT; Rodems K; Noland B; Raymundo M; Walker JJ; North RA
    Hypertension; 2014 Sep; 64(3):644-52. PubMed ID: 25122928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population.
    Diguisto C; Le Gouge A; Piver E; Giraudeau B; Perrotin F
    Prenat Diagn; 2013 Nov; 33(11):1070-4. PubMed ID: 23847040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OS043. Identification and validation of novel markers for the predictionof pre-eclampsia.
    Myers J; Tuytten R; Thomas G; McCowan L; Dekker G; Baker P; Poston L; Kenny L; Simpson N; North R
    Pregnancy Hypertens; 2012 Jul; 2(3):200. PubMed ID: 26105257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida.
    Kulmala L; Phupong V
    Hypertens Res; 2014 Jun; 37(6):538-42. PubMed ID: 24621465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia.
    Tobinaga CM; Torloni MR; Gueuvoghlanian-Silva BY; Pendeloski KP; Akita PA; Sass N; Daher S
    Acta Obstet Gynecol Scand; 2014 May; 93(5):469-76. PubMed ID: 24580069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: prospective evaluation of two algorithms.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    BJOG; 2015 Dec; 122(13):1781-8. PubMed ID: 25471057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
    Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
    Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
    Hirashima C; Ohkuchi A; Takahashi K; Suzuki H; Matsubara S; Suzuki M
    Hypertens Res; 2014 Jun; 37(6):519-25. PubMed ID: 24599015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging new biomarkers of preeclampsia.
    Polsani S; Phipps E; Jim B
    Adv Chronic Kidney Dis; 2013 May; 20(3):271-9. PubMed ID: 23928393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.